A detailed history of Chi Advisors LLC transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Chi Advisors LLC holds 2,180,934 shares of IKNA stock, worth $3.77 Million. This represents 4.65% of its overall portfolio holdings.

Number of Shares
2,180,934
Previous 2,122,040 2.78%
Holding current value
$3.77 Million
Previous $13.9 Million 32.16%
% of portfolio
4.65%
Previous 5.23%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$4.09 - $6.43 $240,876 - $378,688
58,894 Added 2.78%
2,180,934 $9.44 Million
Q2 2023

Aug 11, 2023

BUY
$3.5 - $7.31 $1.61 Million - $3.37 Million
461,168 Added 27.77%
2,122,040 $13.9 Million
Q1 2023

May 11, 2023

BUY
$2.62 - $4.97 $61,570 - $116,795
23,500 Added 1.44%
1,660,872 $5.73 Million
Q4 2022

Feb 13, 2023

BUY
$2.0 - $3.7 $846,136 - $1.57 Million
423,068 Added 34.84%
1,637,372 $4.36 Million
Q3 2022

Nov 09, 2022

BUY
$3.46 - $6.0 $426,849 - $740,202
123,367 Added 11.31%
1,214,304 $4.31 Million
Q2 2022

Aug 12, 2022

BUY
$3.23 - $7.4 $892,067 - $2.04 Million
276,182 Added 33.9%
1,090,937 $4.83 Million
Q1 2022

May 16, 2022

SELL
$5.61 - $13.85 $5 - $13
-1 Reduced -0.0%
814,755 $4.97 Million
Q4 2021

Feb 11, 2022

BUY
$10.52 - $16.96 $5.26 Million - $8.48 Million
499,756 Added 158.65%
814,756 $10.2 Million
Q3 2021

Nov 15, 2021

SELL
$9.82 - $15.23 $4.91 Million - $7.61 Million
-499,756 Reduced 61.34%
315,000 $3.98 Million
Q1 2021

May 14, 2021

BUY
$25.6 - $32.0 $20.9 Million - $26.1 Million
814,756 New
814,756 $23 Million

Others Institutions Holding IKNA

About Ikena Oncology, Inc.


  • Ticker IKNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,257,500
  • Market Cap $62.7M
  • Description
  • Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...
More about IKNA
Track This Portfolio

Track Chi Advisors LLC Portfolio

Follow Chi Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chi Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chi Advisors LLC with notifications on news.